SCHEMBL24378470

SCHEMBL24378470

CC1OC[C@@H](OCc2ccccc2)[C@H](OCc2ccccc2)[C@H]1OCc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 2/20 0.47
ACHE P22303 1/20 0.47
SLC6A2 P23975 1/20 0.43
MAPT P10636 1/20 0.41
CYP2C19 P33261 1/20 0.41
PSEN1 P49768 3/20 0.40
PSEN2 P49810 3/20 0.40
APH1B Q8WW43 3/20 0.40
NCSTN Q92542 3/20 0.40
APH1A Q96BI3 3/20 0.40
PSENEN Q9NZ42 3/20 0.40
PDPK1 O15530 1/20 0.40
MTOR P42345 1/20 0.40
KLK7 P49862 2/20 0.39
KLK5 Q9Y337 2/20 0.39
TSHR P16473 1/20 0.38
CYP1A2 P05177 1/20 0.38
CTSV O60911 1/20 0.38
CTSL P07711 1/20 0.38
CTSB P07858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23278551 1.00 BCHE (0.47) BCHEACHESLC6A2MAPTCYP2C19
SCHEMBL24378345 1.00 BCHE (0.47) BCHEACHESLC6A2MAPTCYP2C19
SCHEMBL29870527 1.00 BCHE (0.47) BCHEACHESLC6A2MAPTCYP2C19
SCHEMBL24378329 1.00 BCHE (0.47) BCHEACHESLC6A2MAPTCYP2C19
SCHEMBL18573747 1.00 BCHE (0.47) BCHEACHESLC6A2MAPTCYP2C19
SCHEMBL25909886 0.89 BCHE (0.46) BCHEACHESLC6A2MAPTCYP2C19
SCHEMBL19620378 0.89 TSHR (0.43) BCHEACHESLC6A2MAPTCYP2C19
SCHEMBL20234401 0.87 SLC6A2 (0.48) BCHEACHESLC6A2MAPTCYP2C19
SCHEMBL20234398 0.87 SLC6A2 (0.48) BCHEACHESLC6A2MAPTCYP2C19
SCHEMBL20226446 0.87 SLC6A2 (0.48) BCHEACHESLC6A2MAPTCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220127239-A1 GLYCOSYL DONOR, PREPARATION METHOD THEREFOR, AND USE THEREOF SICHUAN UNIVERSITY (CN) 2022-04-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220127239-A1 GLYCOSYL DONOR, PREPARATION METHOD THEREFOR, AND USE THEREOF UGGT1, ALG8, FUT6 BCHE 1099/4885ACHE 2611/4885SLC6A2 2076/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.